MAYZENT

Novartis AG

Application Filed: 2018-03-01
Trademark Application Details
Trademark Logo MAYZENT
700
Live/Registered
REGISTERED
Research OneLook Acronym Finder
Serial Number87816240
Registration Number5846370
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic RepresentativeNovartis Pharmaceuticals Corporation
Attorney NameMaury M. Tepper, III
Law Office AssignedL30
Employee NameRICHARDS, SUSAN ANN

Timeline

2018-03-01Application Filed
2018-08-07Published for Opposition
2019-03-27Date of First Use
2019-07-24Location: PUBLICATION AND ISSUE SECTION
2019-08-27Status: Live/Registered
2019-08-27Trademark Registered
2019-08-27Transaction Date

Trademark Applicants & Owners

Owner: Novartis AG
AddressCH-4002 Basel CH 4002
Legal Entity TypeCorporation
Legal Entity State CH

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

MAURY M. TEPPER, III
TEPPER & EYSTER, PLLC
3724 BENSON DRIVE
RALEIGH, NC 27609

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the central nervous system, the immune system, the metabolic system and the musculo-skeletal system; pharmaceutical preparations for the treatment of inflammatory disorders and pain; pharmaceutical preparations for the prevention and treatment of hormonal deficiency and metabolic disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders
GS0051Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the central nervous system, the immune system, the metabolic system and the musculo-skeletal system; pharmaceutical preparations for the treatment of inflammatory disorders and pain; pharmaceutical preparations for the prevention and treatment of hormonal deficiency and metabolic disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2018-03-051 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-03-082 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2018-06-083 DOCK D:Assigned to Examiner
EXAMINERS AMENDMENT -WRITTEN2018-06-194 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED2018-06-195 GNEA F:First Action
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2018-06-196 GNEN O:Outgoing Correspondence
ASSIGNED TO LIE2018-06-197 ALIE A:Allowance for Publication
EXAMINER'S AMENDMENT ENTERED2018-06-198 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2018-06-299 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2018-07-1810 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2018-08-0711 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2018-08-0712 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2018-10-0213 NOAM E:E-Mail
TEAS EXTENSION RECEIVED2019-04-0114 EEXT I:Incoming Correspondence
EXTENSION 1 FILED2019-04-0115 EXT1 S:
EXTENSION 1 GRANTED2019-04-0116 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-04-0317 EXRA E:E-Mail
TEAS STATEMENT OF USE RECEIVED2019-06-2518 EISU I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL2019-07-1619 AITU A:Allowance for Publication
USE AMENDMENT FILED2019-06-2520 IUAF S:
STATEMENT OF USE PROCESSING COMPLETE2019-07-1621 SUPC I:Incoming Correspondence
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2019-07-2422 CNPR P:
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2019-07-2523 SUNA E:E-Mail
REGISTERED-PRINCIPAL REGISTER2019-08-2724 R.PR A:Allowance for Publication

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed